Tuesday, 18 Dec 2018

You are here

What Works in Undifferentiated Arthritis Patients

There is a paucity of guidance on how to best manage patients who may be at risk for rheumatoid arthritis (e.g., first degree relative, seropositivity) and who manifest joint pain but not enough synovitis to be classified as RA.

These researchers undertook a systematic literature review and meta-analysis to address whether disease-modifying antirheumatic drugs (DMARD) or steroid therapy might delay or avoid the onset of RA. They narrowed their review to 10 studies and 1156 patients (with a mean symptom duration of 16.2 weeks) with either undifferentiated arthritis or arthralgia.

They found that DMARD and steroids did not reduce the risk of RA in arthralgia patients after 52 weeks of therapy (pooled OR 0.74, 95% CI 0.37 to 1.49).

On the other hand, there were 7 studies in which DMARD use in patients with undifferentiated arthritis was associated with a significantly reduced the risk (OR 0.73; 95% CI 0.56 to 0.97).

These studies provide modest evidence of DMARD or steroid benefit in patients with undifferentiated arthritis, but not so for arthralgia only patients.

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Rheumatologists' Comments

Do studies use sonography in patients with joints pain ?

More Like This

CV Risks Similar in Systemic Sclerosis and Rheumatoid Arthritis

Interactions between disease-related inflammatory processes and the development of several morbidities have been well-studied in RA, particularly heart disease. This is not the case for the often-lethal SSc (estimated standardized mortality ratio between 2.5 and 4.0). Similarly, there are no studies comparing the most relevant comorbidities between SSc and RA.

PRAIRI Study - Can RA Be Prevented?

B-cell depletion may offer a means of delaying the onset of clinical arthritis in adults at high risk, according to the PRAIRI study - a proof-of-mechanism study in pre-clinical RA patients. 

Rheumatoid Lung Disease Imposes Significant Morbidity and Mortality

Insurance claims data were analyzed for the frequency of interstitial lung disease (ILD) associated with rheumatoid arthritis (RA) and finds that although rare, its frequency increased over time and it is associated with a significant mortality rate. 

The study was done because RA-ILD has been shown to cause significant morbidity and mortality. 

Growing Tick Population Comes with Health Concerns

CNN has published a recent government report from the Tick-Borne Disease Working Group that suggests the US tick population is growing and may bring with it an increase in tick-related illnesses. 

While Lyme disease is the most popular of tick-borne illnesses, there are another 20 known conditions related to tick bites.

Chikungunya Virus Vaccine Developed

Lancet reports on a new vaccine for Chikungunya fever (MV-CHIK) demonstraing excellent safety, tolerability and good immunogenicity, independent of pre-existing immunity against the vector. MV-CHIK is a promising vaccine for the prevention of chikungunya fever.